Amdocs Selling General and Administrative Expense Trend from 2010 to 2022

DOX
 Stock
  

USD 88.17  0.58  0.66%   

Amdocs Selling General and Administrative Expense yearly trend continues to be fairly stable with very little volatility. Selling General and Administrative Expense will likely drop to about 557.8 M in 2022. During the period from 2010 to 2022, Amdocs Selling General and Administrative Expense regression line of anual values had slope of 11,012,730 and arithmetic mean of  470,237,386. Amdocs Interest Expense is fairly stable at the moment as compared to the past year. Amdocs reported Interest Expense of 12.42 Million in 2021. Weighted Average Shares is likely to rise to about 126.6 M in 2022, whereas Direct Expenses is likely to drop slightly above 2.3 B in 2022.
  
Check Amdocs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amdocs main balance sheet or income statement drivers, such as Direct Expenses of 2.3 B, Consolidated Income of 673.8 M or Cost of Revenue of 3.1 B, as well as many exotic indicators such as Interest Coverage of 42.95, Long Term Debt to Equity of 0.16 or Calculated Tax Rate of 13.17. Amdocs financial statements analysis is a perfect complement when working with Amdocs Valuation or Volatility modules. It can also supplement Amdocs' financial leverage analysis and stock options assessment as well as various Amdocs Technical models . Continue to the analysis of Amdocs Correlation against competitors.

Amdocs Quarterly Selling General and Administrative Expense

136.11 Million

Amdocs Selling General and Administrative Expense Breakdown

Showing smoothed Selling General and Administrative Expense of Amdocs Limited with missing and latest data points interpolated. A component of Operating Expenses representing the aggregate total costs related to selling a firm's product and services; as well as all other general and administrative expenses. Direct selling expenses (for example; credit; warranty; and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products; for example telephone expenses; Internet; and postal charges. General and administrative expenses include salaries of non-sales personnel; rent; utilities; communication; etc.Amdocs' Selling General and Administrative Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amdocs' overall financial position and show how it may be relating to other accounts over time.
Selling General and Administrative Expense10 Years Trend
Increasing
Slightly volatile
   Selling General and Administrative Expense   
Share
       Timeline  

Amdocs Selling General and Administrative Expense Regression Statistics

Arithmetic Mean 470,237,386
Geometric Mean 468,127,940
Coefficient Of Variation 10.06
Mean Deviation 35,432,415
Median 464,883,000
Standard Deviation 47,292,507
Range 150,878,250
R-Value 0.91
R-Squared 0.82
Significance 0.00001899
Slope 11,012,730

Amdocs Selling General and Administrative Expense History

2012418.6 M
2013445.1 M
2014440.1 M
2015464.9 M
2016472.8 M
2017481.1 M
2018492.5 M
2019458.5 M
2020487.3 M
2021560.3 M
2022557.8 M

About Amdocs Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Amdocs income statement, its balance sheet, and the statement of cash flows. Amdocs investors use historical funamental indicators, such as Amdocs's Selling General and Administrative Expense, to determine how well the company is positioned to perform in the future. Although Amdocs investors may use each financial statement separately, they are all related. The changes in Amdocs's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Amdocs's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Amdocs Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Amdocs. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Selling General and Administrative Expense560.3 M557.8 M
Amdocs Limited, through its subsidiaries, provides software and services worldwide. Amdocs Limited was founded in 1988 and is headquartered in Saint Louis, Missouri. Amdocs operates under SoftwareInfrastructure classification in the United States and is traded on NASDAQ Exchange. It employs 31000 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Amdocs without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Idea Analyzer Now

   

Idea Analyzer

Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
All  Next Launch Module

Pair Trading with Amdocs

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amdocs position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amdocs will appreciate offsetting losses from the drop in the long position's value.

Moving together with Amdocs

0.73ADBEAdobe Systems Fiscal Year End 15th of December 2022 PairCorr
0.65BKKTBakkt Hldgs Normal TradingPairCorr
The ability to find closely correlated positions to Amdocs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amdocs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amdocs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amdocs Limited to buy it.
The correlation of Amdocs is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amdocs moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amdocs Limited moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amdocs can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to the analysis of Amdocs Correlation against competitors. Note that the Amdocs Limited information on this page should be used as a complementary analysis to other Amdocs' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Complementary Tools for Amdocs Stock analysis

When running Amdocs Limited price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Is Amdocs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amdocs. If investors know Amdocs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amdocs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.089
Market Capitalization
10.8 B
Quarterly Revenue Growth YOY
0.088
Return On Assets
0.0605
Return On Equity
0.15
The market value of Amdocs Limited is measured differently than its book value, which is the value of Amdocs that is recorded on the company's balance sheet. Investors also form their own opinion of Amdocs' value that differs from its market value or its book value, called intrinsic value, which is Amdocs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amdocs' market value can be influenced by many factors that don't directly affect Amdocs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amdocs' value and its price as these two are different measures arrived at by different means. Investors typically determine Amdocs value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amdocs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.